Fact CheckerSign in

NCT05692089Completed

Incidence of Infective Endocarditis in End Stage Renal Disease Patients on Hemodialysis by Transesophageal Echocardiography in Assuit University Hospital

Source: ClinicalTrials.gov · Last updated 31 Jan 2024

Brief summary (registry, in English)

1. To detect in more detail the incidence of infective endocarditis in patients with end stage renal disease (ESRD) on hemodialysis. 2. To compare the relationship between different forms of haemodialysis access type and the related incidence of infective endocarditis. 3. To determine individual risk factors, including type of vascular haemodialysis access, previous valve lesion and immunocompromised patients.

Status (registry)
Completed
Study type
Observational
Enrollment
30 (actual)
First submitted
11 Jan 2023
Start date
1 Feb 2023
Primary completion date
3 Sept 2023
Lead sponsor
Assiut University
NCT number
NCT05692089

What you commit to

  • Study type: Observational
  • Participants enrolled: 30
  • From 1 Feb 2023 to the primary completion date, 3 Sept 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any patient with sepsis due to causes other than infected vascular access.

Who the study is looking for

  • Incidence of infective endocarditis in ESRD that on hemodialysis.
  • Must be fit for Transoesophageal ECHO.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Medicine Assiut University
Coordinator of this site? Confirm its status
AsyutEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.